Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 7,000.00
+510.00 (7.86%)
At close: Jan 16, 2026
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 276.15 billion as of January 16, 2026. Its market cap has increased by 207.86% in one year.
Market Cap
276.15B
Enterprise Value
265.28B
Revenue
25.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,000.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 276.15B, an increase of 284.19%. That is a compound annual growth rate of 20.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 276.15B | 15.84% |
| Dec 30, 2025 | 238.38B | 179.77% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 975.53T |
| SK hynix | 521.98T |
| Hyundai Motor Company | 99.30T |
| LG Energy Solution | 91.49T |
| Samsung Biologics | 90.13T |
| Hanwha Aerospace | 66.83T |
| HD Hyundai Heavy Industries | 65.29T |
| Doosan Enerbility | 61.04T |